- Bonso Electronics International Inc. (BNSO): Important & Key Factors of Technology Stock
- What's the Analyst Recommendation for PhaseBio Pharmaceuticals Inc. (PHAS)?
- Alliance Resource Partners L.P. (ARLP): Important & Key Factors of Energy Stock
- AeroCentury Corp. (ACY) Plunged -11.39%, Can Traders Take Benefit?
- Pixelworks Inc. (PXLW): Important & Key Factors of Technology Stock
Syndax Pharmaceuticals Inc. (SNDX) share price soared 4.40% with the closing price of $16.13 on Tuesday. Syndax Pharmaceuticals Inc. stock has an exchanging volume of 1.23 million shares, which is high, contrasted with its 3-months average volume of 309.00K shares. Its market capitalization has now reached to $671.65M and analysts have a consensus target price of $23.00 in the 12-month period.
Syndax Announces Participation at Three Upcoming Investor Conferences on September 2, 2020 news published at Yahoo.
Citigroup announced it was Upgrade coverage of Syndax Pharmaceuticals Inc. in a research note on May 22, 2020. The analysts assigned a Buy rating to the stock with a price target of $23. H.C. Wainwright rated the stock as a Neutral in a research noted published on May 22, 2020. Citigroup rated the stock as a Neutral in a research note published on May 18, 2020.
SNDX Past Trading Activity
The market tends to become urbane often, in any event, for prepared investors and traders. In any event, when a merchant got what he/she had expected, the market occasionally chooses to move the other way. This instability leads a few traders questioning and re-thinking their moves. This is the reason becoming acquainted with past price performance, just as both long and short time period, is significant. If we look the past performance, during the last one week, SNDX price has dropped by -3.64%. In the course of past three months sees the stock go up around 8.99%, while it has gain 47.98% over the past six months and 83.71% since the start of the year.
SNDX Earning History
Earnings per share are the amount of profit that a company produces during a specific period, which is usually defined as a quarter (three calendar months) or a year. In recent quarter of (Sep 2020), the firm recorded a revenue of 379.0 million, which was higher than the gauge of 400k made by certain experts. For that equivalent quarter, Syndax Pharmaceuticals Inc. posted -$0.42 earnings per share (EPS) which was above the consensus estimate of -$0.45 by $0.03, which represents to an expansion by 6.70%.
SNDX Price Performance
Let us presently take a gander at a portion of its probable help and opposition resistance. Late research on Syndax Pharmaceuticals Inc. has seen its stock exchanging -15.37% underneath its three-month high price. A glance at the opposite side additionally observes stock exchanging +23.70% above its three-month low. A more extensive look sees SNDX exchanging -26.58% beneath its 52-week high and 201.50% above from its 52-week low price.
SNDX Instability & Beta Factor
The Volatility of a stock means that the stock’s drop or increase in the event that the more extensive market drops or rushes. A beta score higher than 1 implies that a stock is profoundly unpredictable while underneath 1 implies that the Volatility of a stock is low. If we look trading Volatility. Its 7-day Volatility is around 6.87%, while it has a month to month instability of 7.95%. The company has an ATR (Average True Range) of 1.20 and a beta factor of 1.79.